Search Videos and More
News
We All Rise Together: Dr. Camille Ragin's Vision for Health Equity in Cancer Care
The statistics are riveting: Throughout the world, approximately 17 percent of the human population are individuals of African descent.
News
National and International Accolades
Meet the bold clinicians and researchers whose work and perseverance push the edge of discovery, and have helped Fox Chase Cancer Center reach our 50th anniversary of excellence in cancer care.
News
From ZIP Code to Genomic Code: First Miami, Now NYC, and Finally, the USA.
Years before Neha Goel, MD, MPH, FACS, became a Fox Chase Cancer Center Fellow in Complex Surgical Oncology, the direction of her life’s work was being shaped.
News
“You must be willing to live and breathe breast cancer.”
Richard Bleicher, MD, FACS, recently appointed Chief of the new Division of Breast Surgery, and a long-term director of the Fox Chase Cancer Center Breast Oncology Fellowship, describes the rigorous training and dedication expected of a Fox Chase Breast Oncology Fellow.
News
GENITOURINARY CANCER PROGRAM
Comprehensive Care That Empowers Patients Through Risk Management, Prevention, Detection, Treatment, and Survivorship Services
Document
The Multidisciplinary Approach at Fox Chase Cancer Center
Where your patient starts their cancer journey matters. Behind every patient at Fox Chase Cancer Center is a multidisciplinary team of highly experienced and trained specialists who provide compassionate care and ensure the best possible outcomes with the
News
FEMALE PELVIC MEDICINE & RECONSTRUCTIVE SURGERY
Fox Chase – Temple Urologic Institute’s program is a comprehensive center serving women with pelvic floor disorders such as incontinence and pelvic order prolapse. Our team has extensive training and experience in the diagnosis and treatment of conditions that affect the pelvic organs. We partner closely with you and your primary care physician, OB/GYN, and urologistto ensure you have the highest level of pelvic care.
News
BENIGN PROSTATE HYPERPLASIA
With one of the largest and most experienced urology teams in the region and the latest treatment capabilities, the Fox Chase-Temple Urologic Institute is a trusted regional leader in treating all types of urologic conditions. Our physicians are available to assist with diagnosing and treating benign prostate hyperplasia, including seeing patients for whom other medical treatments have failed.
News
Like Mother, Like Son
A mother and son’s talents and a duo of DAISY awards.
Course
23rd Annual Highlights of the 2024 San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this education program is designed to help medical, radiation, and surgical oncologists, gynecologists, and radiologists translate the data from key presentations of the 2024 San Antonio Breast Cancer Symposium into practice. New options for the prevention, diagnosis, and treatment of breast cancer and premalignant breast disease will be discussed. In addition, we will address new strategies for optimizing existing treatments.
Course
Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies
The management of advanced kidney, bladder, and prostate cancer is rapidly evolving, and new robotic and minimally invasive surgical techniques are now available. This CME program is designed to address the challenges physicians face in treating these complex cases. Presented by the nationally recognized Fox Chase Cancer Center genitourinary oncology team—comprising experts in urology, radiation therapy, and medical oncology—this program will cover the latest advancements in surgical techniques, radiation therapies, and medical treatments for both localized and advanced bladder, kidney, and prostate cancers.
News
Fox Chase Cancer Center and Lewis Katz School of Medicine Researchers Identify Where to Target Interventions to Reduce Disparities in Aggressive Prostate Cancer
Researchers at Fox Chase Cancer Center and Lewis Katz School of Medicine at Temple University have identified factors that, if addressed, could decrease incidence of aggressive prostate cancer in areas where rates are highest — often Black communities with high rates of poverty.